Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

304 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Renal cell carcinoma.
Rathmell WK, Godley PA. Rathmell WK, et al. Curr Opin Oncol. 2004 May;16(3):247-52. doi: 10.1097/00001622-200405000-00010. Curr Opin Oncol. 2004. PMID: 15069321 Review.
Renal cell carcinoma.
Rathmell WK, Godley PA, Rini BI. Rathmell WK, et al. Curr Opin Oncol. 2005 May;17(3):261-7. doi: 10.1097/01.cco.0000155007.51495.d6. Curr Opin Oncol. 2005. PMID: 15818172 Review.
Molecularly targeted therapy in renal cell carcinoma.
Rathmell WK, Wright TM, Rini BI. Rathmell WK, et al. Expert Rev Anticancer Ther. 2005 Dec;5(6):1031-40. doi: 10.1586/14737140.5.6.1031. Expert Rev Anticancer Ther. 2005. PMID: 16336094 Review.
Renal cell carcinoma.
Rini BI, Campbell SC, Rathmell WK. Rini BI, et al. Among authors: rathmell wk. Curr Opin Oncol. 2006 May;18(3):289-96. doi: 10.1097/01.cco.0000219260.60714.c4. Curr Opin Oncol. 2006. PMID: 16552243 Review.
Renal cell carcinoma.
Rathmell WK, Martz CA, Rini BI. Rathmell WK, et al. Curr Opin Oncol. 2007 May;19(3):234-40. doi: 10.1097/CCO.0b013e3280ad4388. Curr Opin Oncol. 2007. PMID: 17414642 Review.
Renal cell carcinoma.
Rini BI, Rathmell WK, Godley P. Rini BI, et al. Among authors: rathmell wk. Curr Opin Oncol. 2008 May;20(3):300-6. doi: 10.1097/CCO.0b013e3282f9782b. Curr Opin Oncol. 2008. PMID: 18391630 Review.
Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: a phase II trial.
Kim WY, Whang YE, Pruthi RS, Baggstrom MQ, Rathmell WK, Rosenman JG, Wallen EM, Goyal LK, Grigson G, Watkins C, Godley PA. Kim WY, et al. Among authors: rathmell wk. Urol Oncol. 2011 Nov-Dec;29(6):608-13. doi: 10.1016/j.urolonc.2009.09.012. Epub 2009 Dec 21. Urol Oncol. 2011. PMID: 20022268 Clinical Trial.
Neoadjuvant treatment of renal cell carcinoma.
Rathmell WK, Pruthi R, Wallen E. Rathmell WK, et al. Urol Oncol. 2010 Jan-Feb;28(1):69-73. doi: 10.1016/j.urolonc.2009.02.001. Urol Oncol. 2010. PMID: 20123351 Review.
304 results